Lisa Kang is a highly accomplished drug development leader with over 20 years of experience in the biotech/pharmaceutical industry. She is recognized for her strategic and operational expertise in clinical trial design and execution, statistical analysis, and regulatory strategy. Lisa has a proven track record of successful regulatory submissions and approvals, and has extensive experience in interacting with regulatory agencies worldwide, including the EMA, PMDA, and China FDA.
With executive experience in a dynamic biotech company, Lisa has managed clinical development, clinical operations, biometrics, pharmacovigilance, QA, clinical supply chain, and data science teams. She is an expert in state-of-the-art statistical methods and trial design, and has extensive experience in their application across all stages of clinical development, in both small and large biotech/pharmaceutical companies.
Lisa has worked across a range of therapeutic areas, including CNS, oncology, cardiovascular disease, cystic fibrosis, infectious disease, and lysosomal storage disorders such as Pompe disease. She is passionate about bringing innovative treatments to patients in need and is committed to the highest standards of clinical development
Lisa has a BS in Chemistry, a MS in Biostatistics, as well as a MS in Clinical Service Operation.